BriaCell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Cash & Equivalents	29.9	10.49	0.86	21.25	41.04	57.27
Short-Term Investments	-	7.37	-	-	-	-
Cash & Short-Term Investments	29.9	17.87	0.86	21.25	41.04	57.27
Cash Growth	496.44%	1972.44%	-95.94%	-48.22%	-28.34%	269412.38%
Other Receivables	-	-	0.74	-	0.02	0.01
Receivables	-	-	0.74	-	0.02	0.01
Prepaid Expenses	2.28	2.06	2.06	5.7	1.28	0.52
Total Current Assets	32.18	19.93	3.65	26.95	42.35	57.8
Property, Plant & Equipment	0.25	0.3	0.39	-	-	-
Long-Term Investments	0.58	0.52	0.42	0	0	0
Other Intangible Assets	0.18	0.18	0.2	0.22	0.23	0.25
Other Long-Term Assets	0.41	0.72	1.21	-	-	-
Total Assets	33.59	21.65	5.87	27.16	42.58	58.04
Accounts Payable	1.88	3.28	7.17	1.12	0.46	0.21
Accrued Expenses	1.31	0.69	0.29	0.68	0.48	0.34
Total Current Liabilities	3.19	3.98	7.46	1.8	0.94	0.56
Long-Term Debt	-	-	-	-	-	0.03
Other Long-Term Liabilities	0.2	0.34	1.1	29.14	31.31	29.79
Total Liabilities	3.38	4.32	8.56	30.94	32.25	30.37
Common Stock	117.12	101.74	72.17	69.59	65.59	54.77
Additional Paid-In Capital	-	-	-	-	-	2.18
Retained Earnings	-127.17	-111.76	-85.44	-80.65	-60.35	-29.14
Comprehensive Income & Other	40.97	27.9	10.89	7.28	5.09	-0.14
Total Common Equity	30.92	17.88	-2.38	-3.78	10.33	27.67
Minority Interest	-0.7	-0.55	-0.3	-	-	-
Shareholders' Equity	30.21	17.33	-2.68	-3.78	10.33	27.67
Total Liabilities & Equity	33.59	21.65	5.87	27.16	42.58	58.04
Total Debt	-	-	-	-	-	0.03
Net Cash (Debt)	29.9	17.87	0.86	21.25	41.04	57.24
Net Cash Growth	496.44%	1972.44%	-95.94%	-48.22%	-28.30%	-
Net Cash Per Share	20.16	42.23	7.86	204.08	397.33	1899.79
Filing Date Shares Outstanding	7.25	1.88	0.12	0.11	0.1	0.1
Total Common Shares Outstanding	7.25	1.88	0.12	0.11	0.1	0.1
Working Capital	28.99	15.95	-3.81	25.15	41.41	57.24
Book Value Per Share	4.26	9.49	-19.54	-35.45	99.84	271.83
Tangible Book Value	30.74	17.7	-2.58	-3.99	10.1	27.43
Tangible Book Value Per Share	4.24	9.39	-21.18	-37.47	97.61	269.42
Machinery	-	0.46	0.46	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.